MedPath

葵花药业集团（伊春）有限公司

Ownership
-
Established
2001-02-12
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

Altretamine

Product Name
六甲蜜胺
Approval Number
国药准字H23020449
Approval Date
Apr 22, 2025
NMPA

Nicardipine Hydrochloride

Product Name
盐酸尼卡地平
Approval Number
国药准字H23020452
Approval Date
Apr 22, 2025
NMPA

Tiapride Hydrochloride

Product Name
盐酸硫必利
Approval Number
国药准字H23022747
Approval Date
Apr 22, 2025
NMPA

Ifosfamide

Product Name
异环磷酰胺
Approval Number
国药准字H20066045
Approval Date
Apr 22, 2025
NMPA

胃康灵胶囊

Approval Number
国药准字Z20054702
Approval Date
Aug 19, 2024
NMPA

消栓通络片

Approval Number
国药准字Z20055576
Approval Date
Mar 15, 2022
NMPA

海洋胃药

Approval Number
国药准字Z20033223
Approval Date
Dec 29, 2021
NMPA

复方丹参片

Approval Number
国药准字Z20053183
Approval Date
Sep 25, 2021
NMPA

维C银翘片

Approval Number
国药准字Z23022105
Approval Date
Jun 14, 2020
NMPA

复方川贝精片

Approval Number
国药准字Z23022142
Approval Date
Jun 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.